HOME >> BIOLOGY >> NEWS
Virginia Tech researcher receives $1.8 million to study Arabidopsis genome

Blacksburg, Va. -- Virginia Bioinformatics Institute (VBI) researcher Vladimir Shulaev has been awarded a $1.8 million grant from the National Science Foundation (NSF) for the collaborative "Arabidopsis 2010" research project. Through such projects, the NSF hopes to determine the function of 25,000 genes in Arabidopsis thaliana by the year 2010. The research conducted at VBI will examine parts of the Arabidopsis genome that are involved in essential functions of the plant, leading to improvements in crop yield and nutritional value.

Shulaev, along with researchers from the University of Michigan and The Salk Institute for Biological Studies, is working to understand the function of the SABATH faculty of methyltransferase genes in plants. These genes are believed to have profound effects on plant physiology and reproduction by mediating processes in plants controlled by signaling and hormone molecules.

Using gene expression profiling, metabolite profiling, and genetic manipulations, the team will learn more about plant physiology and then translate that information to other crops. "The 'Arabidopsis 2010' project will provide essential information about discovering an organism's chemical repertoire," Shulaev said.

The project will also support a number of minority high school, undergraduate and graduate students. This interdisciplinary project will provide the students with a unique research experience. In addition, methods and materials developed in this investigation will be used to train undergraduate students in formal lab courses.

VBI, a Commonwealth of Virginia shared resource, serves as a flagship bioinformatics research institute wedding cutting-edge biological research with state-of-the-art computer science. By integrating experimental and computational laboratories, VBI provides a unique research platform to all stakeholders on a cost-recovery basis. More information about VBI is available online at:

Contact: Neysa Call
necall@vt.edu
540-231-1259
Virginia Tech
17-Dec-2003


Page: 1 2

Related biology news :

1. Two Virginia Tech energy-related inventions win R&D 100 awards
2. Virginia Tech researchers to release findings on Smith River Project
3. Virginia Tech professor honored with DeLaval Award
4. Virginia Techs smelly corpse plant due to bloom Aug. 4
5. Virginia Bioinformatics Institute researcher advances fight against sudden oak death disease
6. Virginia Center for Coal and Energy Research helps implement global climate change initiative
7. Cell cycle research earns biologist Virginias top scientist award
8. Virginia Tech-led group receives third five-year international biodiversity grant
9. Virginia Tech and North Carolina State University to run Forest Nutrition Research Cooperative
10. Virginia Bioinformatics Institute central to Regional Center of Excellence
11. NIH awards $1 million to Virginia Bioinformatics Institute to study biochemical network modeling

Post Your Comments:
(Date:5/23/2013)... Inside the natural history museums of the world are ... and beetles to flowers, mushrooms and grasses, all stacked, ... The rich and diverse collections could be critical to ... face of a growing human footprint if only ... project, brought to life with the help of a ...
(Date:5/22/2013)... investigators also conclude that the 20 percent reduction ... (LDCT) versus chest X-ray (CXR) screening previously reported ... experienced screening centers in the United States. , ... their patients about the benefits and risks of ... the New England Journal of Medicine ...
(Date:5/22/2013)... engineering drastically reduces the time and effort needed ... of biotechnology, scientists are reporting. Published in the ... paves the way for more rapid development of ... other activities. , Keith Shearwin and colleagues explain ... genetic material DNA into a bacterium,s genome is ...
Breaking Biology News(10 mins):CU-Boulder helps tap crowds to digitize museum records of bugs and plants 2CU-Boulder helps tap crowds to digitize museum records of bugs and plants 3CU-Boulder helps tap crowds to digitize museum records of bugs and plants 4NLST: CT detects twice as many lung cancers as X-ray at initial screening exam 2NLST: CT detects twice as many lung cancers as X-ray at initial screening exam 3
(Date:5/23/2013)... May 23, 2013 Virobay, Inc. today announced ... has reached an important milestone, as Virobay has now ... a selective cathepsin S inhibitor.   The ... randomized, placebo-controlled study designed to evaluate the safety, tolerability, ... healthy adults. "The initiation of this Phase ...
(Date:5/23/2013)... On April 19th the Center for Disease ... the growing antibiotic resistant bacteria that may be lurking ... study were released late last month showing higher antibiotic ... years. For those suffering from bacteria driven acne, Probiotic ... in food, may eventually help breed acne causing bacteria. ...
(Date:5/23/2013)... 2013 Northwest Biotherapeutics (NASDAQ: NWBO ... personalized immune therapies for solid tumor cancers, announced ... year,s American Society Of Clinical Oncology (ASCO) meeting in ... role in immune therapy.  (Logo: http://photos.prnewswire.com/prnh/20110329/SF73084LOGO ... the pre-eminent conference focused on clinical treatment of cancer, ...
(Date:5/23/2013)... EASTON, Mass. , May 23, 2013 ... today announced that the Company will host a teleconference ... to provide a business update. The teleconference information is ... Time: 11:00 a.m. Eastern Daylight Time (EDT) ... ); (302) 607-2001 (Int,l) Passcode: VS22823 ...
Breaking Biology Technology:Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 2Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 3Acne Cream, Probiotic Action Shares News on How Some Food may Breed Acne Causing Bacteria 2NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 2NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 3Pressure BioSciences, Inc. to Discuss First Quarter 2013 Financial Results and Provide Business Update 2
Cached News: